Citius Pharmaceuticals Inc CTXR:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 04/22/24 EDT
0.7342quote price arrow down-0.0202 (-2.6776%)
Volume
1,279,363
52 week range
0.60 - 1.62
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.7342
  • 52 Week High1.62
  • 52 Week High Date04/24/23
  • 52 Week Low0.60
  • 52 Week Low Date02/08/24

Key Stats

  • Market Cap116.807M
  • Shares Out159.09M
  • 10 Day Average Volume1.39M
  • Dividend-
  • Dividend Yield-
  • Beta1.54
  • YTD % Change-2.95

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.7342
  • 52 Week High1.62
  • 52 Week High Date04/24/23
  • 52 Week Low0.60
  • 52 Week Low Date02/08/24
  • Market Cap116.807M
  • Shares Out159.09M
  • 10 Day Average Volume1.39M
  • Dividend-
  • Dividend Yield-
  • Beta1.54
  • YTD % Change-2.95

RATIOS/PROFITABILITY

  • EPS (TTM)-0.25
  • P/E (TTM)-2.88
  • Fwd P/E (NTM)-4.74
  • EBITDA (TTM)-38.82M
  • ROE (TTM)-42.48%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/10/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Citius Pharmaceuticals Inc

 

Profile

MORE
Citius Pharmaceuticals, Inc. is a late-stage biopharmaceutical company. It develops and commercializes critical care products with a focus on oncology, anti-infectives in adjunct cancer care, prescription products and stem cell therapy. Its products include LYMPHIR, Mino-Lok, Halo-Lido, NoveCite and Mino-Wrap. LYMPHIR is an engineered IL-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok is an...
Leonard Mazur
Executive Chairman of the Board, Chief Executive Officer, Company Secretary
Myron Holubiak
Executive Vice Chairman of the Board
Jaime Bartushak
Chief Financial Officer, Chief Business Officer
Myron Czuczman M.D.
Chief Medical Officer, Executive Vice President
Ilanit Allen
Vice President - Corporate Communications and Investor Relations
Address
11 Commerce Dr Fl 1
Cranford, NJ
07016-3501
United States

Top Peers

SYMBOLLASTCHG%CHG
NVCT
Nuvectis Pharma Inc
7.10+0.28+4.11%
RANI
Rani Therapeutics Holdings Inc
6.67-0.40-5.66%
LPTX
Leap Therapeutics Inc
3.21+0.41+14.64%
ANVS
Annovis Bio Inc
11.49+1.43+14.21%
IMUX
Immunic Inc
1.23+0.05+4.24%